Microorganisms as Architects of Modern Biotechnology: Enhancing Gene Editing Tools for the Development of Resilient Biological Systems

Abstract
Modern biotechnology is all about microorganisms, which not only make excellent model systems, but also important reservoirs of molecular machinery that propel progress in genetic engineering. The identification and description of microbial defense systems and regulation, such as CRISPR-Cas adaptive immunity, systems of transpose weaving and genome rearrangement via recombinases have given the theoretical and practical foundation to specific, programmable gene editing technologies. Through the knowledge of microbial genomics, structural biology and evolutionary adaptation, the scientists have redesigned these native microbial pathways to create versatile biotechnology vectors more specific, more faithful and scalable. The tools allow building resilient biological systems with the capabilities to withstand genetic stability, endure biotic and abiotic stress and perform optimally in metabolic efficiency. Further, microbial enzyme incorporation with artificial regulatory networks has increased the functionalities of genome editing platforms connecting basic microbiology and practical biotechnology. With microorganisms still inspiring and informing the design of new generation editing systems, they will still be invaluable in providing adaptive, sustainable and high-performance solutions in the fields of agriculture, medicine and environmental management by using the natural world.

Keywords: Microorganisms, Biotechnology, Gene editing, CRISPR-Cas systems, Microbial enzymes, Genome engineering, Biological resilience, Stress tolerance, Synthetic biology, Molecular biotechnology

1. Introduction

Before the field of biotechnology was established, its major advancement relied on microorganisms. Good things came to those civilizations were unaware of utilizing microbial metabolism in the fermentation of bread, brewing and dairy production¹. These pre-industrial advancements formed the basis of microbiology in industry and showed the ability of microorganisms to catalyze the controlled biological changes. The introduction of microscopy and germ theory transformed microorganisms into experimental systems of research and practical use, where new fields of biological research and applied science were possible². The twentieth century was a turning point due to the emergence of molecular biology. Bacteria and bacteriophages were used as a model in the discovery of basic principles of gene control, replication and recombination³. The application of the bacterial plasmid and restriction enzyme has brought about recombinant DNA technology which has solidified microorganisms to be at the center of modern biotechnology⁴. These technologies made it possible to manipulate genetic material with great precision and preconditioned high-end genome engineering. The next big advance in this process is gene editing. Gene editing, in contrast to previous techniques relying on random mutagenesis or transgenic methodology, has made genomes predictably, efficiently and specifically altered⁵. Most of these technologies were a direct evolution of microbial defense and repair mechanisms that developed in high-stress environmental and biological conditions. The biological systems that can keep their functions intact despite stress and adjust to changing conditions are defined as resilience⁶. In crops, resilience is manifested through pathogen tolerance, drought tolerance, salinity tolerance and extreme temperatures. In medicine, it entails long-term treatment effects and resistant disease course⁷. The present review addresses the involvement of microorganisms, their diversity and evolutionary innovations in the development of gene editing technologies and the current utilization of these technologies in the development of resilient biological systems in the areas of agriculture, medicine and environmental biotechnology (Figure 1).

Figure 1: Microbial contributions to biotechnology and gene editing, illustrating the transition from natural microbial defense systems to engineered resilience in plants, microbes and animals.

2. Microbial Diversity as a Source of Gene Editing Tools

The genetic diversity and evolutionary plasticity of microorganisms is extraordinary and thus has allowed them to adapt to very diverse ecological and environmental factors⁸. Their high rates of rapid replication, high rates of mutation and horizontal gene transfer make it easy to evolve advanced molecular systems which imbue them with resistance to viral infection, chemical stress and other forms of selective pressure⁹. Such adaptive mechanisms have produced an extensive repertoire of enzymes with sequence-specific recognition, cleavage, modification and repair capabilities that have since become the molecular basis of contemporary biotechnology¹⁰. One of the earliest discoveries in the microbial world to revolutionize the study of genetics was the discovery of bacterial restriction endonucleases, which are part of restriction-modification systems that protect host genomes against foreign nucleic acids. Their ability to cut DNA at specific sequences formed the conceptual and technical foundation of recombinant DNA technology, which triggered the development of cloning, genetic mapping and sequencing¹¹. In addition to restriction enzymes, microorganisms express a rich collection of molecular machines, such as recombinases, integrases, transposases and RNA-guided nucleases (Table 1), each of which had been evolved to mediate genomic rearrangements and repair with extraordinary efficiency¹². Eukaryotic models Yeasts in particular have been used as useful models because of their strong systems of homologous recombination, with which it is easy to manipulate the genome¹³. These microbial mechanisms, together, act as a huge and constantly growing genetic toolkit and are a source of inspiration in the creation of advanced gene editing platforms and support the idea that microorganisms are at the heart of any current biotechnology¹⁴.

Table 1: Major gene editing tools derived from microorganisms and their biological origins.

3. Microbial Origins and Evolution of CRISPR-Based Technologies

The identification of regularly spaced short repeats of palindromes which are clustered and interspaced (CRISPR) in bacterial and archaeal genomes was initially considered a genetic anomaly with no known function. Later research however found that these repetitive loci, along with the respective Cas (CRISPR-associated) proteins, represent an adaptive immune system that procures the prokaryotes to identify and resolve invading genetic components¹⁸. The CRISPR arrays are viewed as a molecular memory bank, a collection of short foreign DNA segments (spacers) previously obtained upon infections. The CRISPR RNAs derived as spacers mediate degradation and cleavage upon reinfection of other genome sequences complementary to these crRNAs by Cas nucleases, which find their target via these spacers¹⁹. It is a sequence-specific immune defense that is one of the complexes examples of molecular evolution in prokaryotes, an evolutionary arms race between microorganisms and their viral predators²⁰.

CRISPR-Cas systems are highly diverse and fall into various classes, types and subtypes depending on their architecture and mode of action. Such diversity is a direct consequence of centuries of coevolution with mobile genetic elements resulting in specialized Cas proteins that vary in their recognition of targets, cleavage factors and complexity in regulation²¹. This variation has proved to be a great source of molecular parts which could be customized to be exact genetic manipulation.

The re-use of CRISPR-Cas systems to edit the genome brought a change in paradigm in biotechnology. This would only be possible through stricter molecular engineering - simplification of the two parts of RNA into a single-guide RNA (sgRNA), optimization of Cas nuclease genes to be expressed in a eukaryotic system and the introduction of regulatory modules to finely tweak genome editing activity; time and space²². All of these changes made a natural microbial defense system a modular, programmable system that is capable of editing any genome with high precision. In the present day, CRISPR-based technologies have become the basis of a broad range of applications, encompassing fundamental genetic research and therapeutics development (Figure 2), crop enhancement and synthetic biology and are an example of how microbial innovation is redefining the scope of biological engineering²³.

Figure 2: Stepwise representation of CRISPR-Cas activity from microbial immunity to engineered genome editing.

4. Microorganisms as Model Systems for Gene Editing Optimization

Microorganisms are crucial experimental systems to the design, assessment and optimization of gene editing techniques. Their genetic tractable nature, growth rate and well-characterized molecular systems render them the best in testing nuclease activity, testing target specificity and testing cellular responses to genome manipulation²⁴. Bacterial systems, especially, offer an efficient platform to screen the enzyme variants in high-throughput, allowing the effective identification of constructs with enhanced cleavage activity, reduced off-target effects and reduced cytotoxicity²⁵. Bacterial genomes are simple and there exist potent genetic technologies enabling an accurate quantitative study of the efficiency of editing and repair dynamics.

Yeasts would serve as a useful model in which to test editing strategies, which are more closely related to higher life. Their very efficient homologous recombination apparatus assists in pinpointing genes precisely and in detail examining DNA repair pathways, such as homologous recombination and non-homologous end joining²⁶. These tools have rendered Saccharomyces cerevisiae and related species useful as a way to elucidate mechanisms underlying the repair of double-strand breaks and as a benchmark to engineered nucleases, including CRISPR-Cas, TALENs and zinc-finger nucleases²⁷.

Synthetic biology has further increased the range of applications of microbes by making possible the assembly of programmable gene circles and modular plasmids systems to recreate complicated regulatory patterns²⁸. These engineered microbial platforms offer a controlled setting to evaluate guide RNA design, Cas version behavior and repair template efficiency²⁹. By undergoing multiple cycles of microbial screening and optimization, editing technologies can be rationally optimized before their use in multicellular organisms which enhances editing fidelity, reduces risk and accelerates the process of translational research in the field of biotechnology, medicine and agriculture³⁰.

5. Microbial Enhancement of Gene Editing Efficiency and Precision

Not only do microbial systems serve as natural repositories of gene editing machineries, but also, they are dynamic platforms in which they are constantly enhanced. Directed evolution and rational engineering of bacterial hosts have enabled scientists to produce more fidelity, less off-target and expanded protospacer adjacent motif (PAM) compatible modified Cas enzymes³¹. Such iterative selection systems take advantage of the fast replication rate and genetic adaptability of microbes to hurry molecular innovation that would otherwise be troublesome to accomplish in more complicated organisms. Besides, the elements of regulation that are based on microbial genomes, including promoters, terminators and ribosome binding sites, offer generalized means of controlling the expression levels of the editing elements with astounding specificity, which can lead to editing results that are context-specific and highly regulated³². Massive microbial screening libraries also enable the systematic testing of guide RNA designs, enabling the strong design sequences to be identified very quickly and with minimal unwanted genomic changes³³. Together, these microbial methods comprise the experimental foundation to evolve, test and improve future generation gene editing systems that merge molecular accuracy and functional dependability in a variety of biological settings (Table 2).

Table 2: Microbial strategies used to enhance gene editing performance.

6. Development of Resilient Agricultural Systems

The application of gene editing, especially microbial-based gene editing methods like CRISPR-Cas systems, has revolutionized plant biotechnology by empowering the ability to specifically manipulate genes that regulate disease resistance, abiotic stress tolerance and yield stability in key crops³⁷. Such directed genetic alterations are capable of augmenting inherent plant defenses to pathogens, fine-tune stress-response pathways and augment metabolic effectiveness and has a direct bearing on productivity and crop resilience³⁸. In addition to these interventions, plant-associated microorganisms, such as rhizobacteria, endophytes and mycorrhizal fungi, enhance the health of plants in a variety of ways: they facilitate nutrient uptake by fixation and solubilization of nitrogen and phosphorus, regulate immune functions, release phytohormones that control plant growth and stress adaptation and remodel the rhizosphere to resist environmental variations in the form of drought, salinity and temperature extremes³⁹. A comprehensive approach to agriculture can be achieved by combining gene-edited crops with a customized beneficial microbial community or engineered microbial inoculants to improve productivity, minimize chemical fertilizer and pesticide usage and nutritionally complement the entire ecosystem⁴⁰. The interface between accurate genomic based interventions and the engineering of microbial ecosystems is a futuristic perspective of sustainable agriculture that has the potential to address the issues of climatic variability and food security in the world⁴¹.

7. Microorganisms in Medical and Therapeutic Resilience

A variety of therapeutic gene editing strategies rely on microbial systems as both the minimal molecular machinery and the principles of delivery that are employed in existing systems. Cas nucleases are now being expressed in large amounts in microbial expression hosts including Escherichia coli⁴² and yeast, making it possible to isolate highly active enzymes to use in ex vivo editing applications and develop ribonucleoprotein-based therapeutics. Besides, the microbial and viral vectors research, such as bacteriophages and other viral delivery systems, has informed the design principles of contemporary gene delivery vehicles that are employed to deliver editing elements into human cells⁴³.

Gene editing is currently under study in the clinic to treat monogenic inherited disease, engineer immune cells, including CAR-T and CAR-NK cells and increase host resistance to infectious diseases by targeting viral entry receptors or critical immune controllers⁴⁴. Regardless of these developments, key challenges remain, especially efficient and tissue-specific delivery, attenuation of innate and adaptive immune responses to exogenous nucleases and delivery vehicles and longevity and safety of edited genomes and off-target effects, which have oncogenic and deleterious effects. Continued knowledge in the field of microbial biology such as the identification of new Cas effectors, anti-CRISPR systems and better microbial-based delivery methods are still essential in overcoming these limitations and in achieving the full potential of gene editing technologies in the treatment of diseases⁴⁵.

8. Environmental and Industrial Biotechnology Applications

Microbial gene editing provides an opportunity to create robust strains that can withstand shifts in pH, heat, salinity and toxic load as well as effectively break down intricate pollutants like hydrocarbons, plastics, dyes and heavy metals. To accomplish stable, robust degradation of irregular environmental conditions, engineered microbial consortia based on complementary metabolic pathways and syntrophic interactions are increasingly being used in bioremediation and wastewater treatment systems⁴⁶.

Precise genome editing of chassis microorganisms in the field of industrial biotechnology facilitates the optimization of central metabolism, stress response networks and by-product formation to enhance strain robustness, product yield and process stability in large-scale fermentations (Table 3). These developments help to facilitate more sustainable manufacturing in that it allows to conduct efficient bioproduction of fuels, chemicals, materials and high-value bioproducts using fewer resource inputs and less impact on the environment than a conventional petrochemical process⁴⁷.

Table 3: Applications of microbe-enhanced gene editing in resilience development.

9. Ethical, Biosafety and Regulatory Considerations

There are important biosafety issues associated with the application of microbial gene editing technologies, including the possibility of unintentional release into the environment and horizontal gene transfer that has the potential to produce an impact on a non-target population or ecosystem. The rigorous, case-specific risk evaluation of responsible innovation in this area includes host range, genetic stability, environmental persistence and potential gene transfer, strong physical and biological containment measures and a clear description of experimental procedures⁵¹.

Regulatory frameworks in the world regulate genetically modified and genome-edited microbes differently, with dissimilarity in risk assessment criteria, process-based versus product-based control and enforcement ability and makes cross-border research, commerce and environmental discharge difficult⁵². These gaps emphasize the necessity of increased international coordination and harmonization of biosafety and biosecurity regulations to make sure that the technologies of microbial gene editing are used safely, transparently and responsibly all over the world.

10. Future Perspectives and Emerging Directions

Highly unexploited and untapped reservoirs of potential gene editing enzymes, such as nucleases, recombinases and regulatory proteins with new specificities and modes of action, are found in uncultured microbial diversity. The current levels of metagenomics can now directly sequence environmental DNA of soil, marine environments and host-associated microbiomes, permitting the discovery of candidate effector proteins in-silico without any microbial culture⁵³. This is being accelerated by machine learning and other computational methods that are able to predict enzyme structure, activity and target specificity given sequence information to prioritize promising candidates to be experimentally validated.

Synthetic biology models make it easy to functionally characterize these enzymes by enabling them to be heterologous expressed, assembled in modules to editing platforms and tested in microbial and eukaryotic hosts. In the future, it is anticipated that microbiome engineering may be more closely coupled to microbial genome engineering, to create dynamically-adaptable microbial communities and host-microbe interactions tailored to environmental, agricultural and clinical settings and that it can be stress-resilient and functionally programmable. These integrative strategies have placed uncultured microbial diversity at the foundation of the coming generation of adaptive resilient biological systems.

11. Conclusion

Microorganisms along with their derivatives have played a central role in all the key developments in gene editing, as the inspiration and source of the molecular reagents with which modern biotechnology is built. The first manipulations of DNA and the recombinant DNA technology were made possible by the discovery of restriction endonucleases in bacteria, which initially developed as defense systems against bacteriophages. Likewise, prokaryote adaptive immune systems, including CRISPR-Cas systems, developed the ability to sense and silence foreign genetic material with exceptional specificity; this has since found applications in a variety of other organisms as remarkably accurate and programmable genetic genome editing systems. In addition to DNA cleavage, microorganisms have evolved an arsenal of repair pathways, recombination pathways and regulatory circuits that have inspired the synthetic biology strategies of regulating gene expression, improved genome stability and optimizing metabolic pathways. Microbial evolution has led to the development of molecular innovations under sustained environmental pressures (such as viral predation, resource competition and abiotic stress) that portray efficiency, specificity and adaptability. With biotechnology being more focused on resilience, these microbial-based systems are set to lead to the creation of sustainable agriculture via disease resistant and stress tolerant crops, future medical therapies with precision gene and cell-based therapies and bioengineered systems that are environmentally resilient and adaptable to changing environments. Here, microorganisms are not simply instrumenting but another innovative engine as it helps in the rational planning of robust biological systems that connect basic research and practical uses.

12. References

1.                Steinkraus KH. Origin and history of food fermentations. In Handbook of food and beverage fermentation technology. CRC Press, 2004: 22-30.

2.                Khodavirdipour A, Mehregan M, Rajabi A, et al. Microscopy and its application in microbiology and medicine from light to quantum microscopy: a mini-review, 2019.

3.                Luria SE, Dulbecco R. Genetic recombinations leading to production of active bacteriophage from ultraviolet inactivated bacteriophage particles. Genetics, 1949;34(2): 93.

4.                Khan S, Ullah MW, Siddique R, et al. Role of recombinant DNA technology to improve life. International journal of genomics, 2016;2016(1): 2405954.

5.                Gan SY, Maggs CA. Random mutagenesis and precise gene editing technologies: applications in algal crop improvement and functional genomics. European Journal of Phycology, 2017;52(4): 466-481.

6.                Karatsoreos IN, McEwen BS. Annual research review: The neurobiology and physiology of resilience and adaptation across the life course. Journal of Child Psychology and Psychiatry, 2013;54(4): 337-347.

7.                Mohapatra R, Naan T, Chitra M, et al. A Review on Biotechnological Innovations in Developing Stress‐Tolerant Crops for Adverse Environmental Conditions. Journal of Scientific Research and Reports, 2024;30(7): 901-920.

8.                Torsvik V, Øvreås L. Microbial diversity, life strategies and adaptation to life in extreme soils. In Microbiology of extreme soils. Springer, 2008: 15-43.

9.                Hossain AZ, Chowdhury AMA. Understanding the evolution and transmission dynamics of antibiotic resistance genes: a comprehensive review. Journal of Basic Microbiology, 2024;64(10): e2400259.

10.             O'Brien PJ. Catalytic promiscuity and the divergent evolution of DNA repair enzymes. Chemical reviews, 2006;106(2): 720-752.

11.             Murray NE. DNA restriction and modification. The Desk Encyclopedia of Microbiology, 2003;358.

12.             Rohmat RK, Irvine TC, Hina-Nilesh Joshi S, et al. Emerging trends in genome integration tools for precision engineering of diverse bacterial species. Synthetic Biology, 2025;019.

13.             Ding Y, Wang K-F, Wang W-J, et al. Increasing the homologous recombination efficiency of eukaryotic microorganisms for enhanced genome engineering. Applied Microbiology and Biotechnology, 2019;103(11): 4313-4324.

14.             Amir M, Kanwal P, Maqsood A, et al. Plant-Virus Interaction Concepts Guiding the Development of Precise Molecular Detection Methods. Journal of Microbiological Sciences, 2026;5(01): 62-73.

15.             Sharp PM. Molecular evolution of bacteriophages: evidence of selection against the recognition sites of host restriction enzymes. Molecular biology and evolution, 1986;3(1): 75-83.

16.             Barrangou R. The roles of CRISPR-Cas systems in adaptive immunity and beyond. Current opinion in immunology, 2015;32: 36-41.

17.             Hallet B, Sherratt DJ. Transposition and site-specific recombination: adapting DNA cut-and-paste mechanisms to a variety of genetic rearrangements. FEMS microbiology reviews, 1997;21(2): 157-178.

18.             van Beljouw SP, Sanders J, Rodríguez-Molina A, et al. RNA-targeting CRISPR–Cas systems. Nature Reviews Microbiology, 2023;21(1): 21-34.

19.             McGinn J, Marraffini LA. Molecular mechanisms of CRISPR–Cas spacer acquisition. Nature Reviews Microbiology, 2019;17(1): 7-12.

20.             Rocha EP, Bikard D. Microbial defenses against mobile genetic elements and viruses: Who defends whom from what? PLoS biology, 2022;20(1): e3001514.

21.             Senkevich TG, Yutin N, Wolf YI, et al. Ancient gene capture and recent gene loss shape the evolution of orthopoxvirus-host interaction genes. MBio, 2021;12(4).

22.             Lavasanifar P. Comparative analysis of guide RNA design tools Hochschule Rhein-Waal, 2022.

23.             Ali F, Hameed A, Rehman A, et al. CRISPR System Discovery, History and Future Perspective. OMICs‐based Techniques for Global Food Security, 2024: 159-170.

24.             Sarkar, P., Laxmi, V., Chhetry, S., et al. Conventional and Modern Genetic Approaches for Improvement of Industrially Important Strains. In Bioprocess Engineering and Technology. CRC Press, 2025: 60-88.

25.             Addis HG, Carlson EE. Recent advances in high-throughput screening methods for small molecule modulators in bacteria. Current opinion in chemical biology, 2025;85: 102571.

26.             Sun Y, McCorvie TJ, Yates LA, et al. Structural basis of homologous recombination. Cellular and Molecular Life Sciences, 2020;77(1): 3-18.

27.             Thompson MK, Sobol RW, Prakash A. Exploiting DNA endonucleases to advance mechanisms of DNA repair. Biology, 2021;10(6): 530.

28.             Khalil AS, Collins JJ. Synthetic biology: applications come of age. Nature Reviews Genetics, 2010;11(5): 367-379.

29.             Liu L, Li W, Li J, et al. Circular guide RNA for improved stability and CRISPR-Cas9 editing efficiency in vitro and in bacteria. ACS Synthetic Biology, 2022;12(2): 350-359.

30.             Buyel JF, Stöger E, Bortesi L. Targeted genome editing of plants and plant cells for biomanufacturing. Transgenic research, 2021;30(4): 401-426.

31.             Kondrateva E, Demchenko A, Lavrov A, et al. An overview of currently available molecular Cas-tools for precise genome modification. Gene, 2021;769: 145225.

32.             Mitschka S, Mayr C. Context-specific regulation and function of mRNA alternative polyadenylation. Nature reviews Molecular cell biology, 2022;23(12): 779-796.

33.             Pan C, Li G, Bandyopadhyay A, et al. Guide RNA library-based CRISPR screens in plants: opportunities and challenges. Current Opinion in Biotechnology, 2023;79: 102883.

34.             Hibbert EG, Dalby PA. Directed evolution strategies for improved enzymatic performance. Microbial Cell Factories, 2005;4(1): 29.

35.             Peng B, Williams TC, Henry M, et al. Controlling heterologous gene expression in yeast cell factories on different carbon substrates and across the diauxic shift: a comparison of yeast promoter activities. Microbial Cell Factories, 2015;14(1): 91.

36.             Calvo-Villamañán A, Ng JW, Planel R, et al. On-target activity predictions enable improved CRISPR–dCas9 screens in bacteria. Nucleic acids research, 2020;48(11): e64.

37.             Srikanth P, Sivakumar D, Sharma A, et al. Recent developments in omics techniques for improving plant abiotic stress using microbes. International Journal of Environmental Science and Technology, 2025;22(5): 3787-3810.

38.             Khan N. Exploring plant resilience through secondary metabolite profiling: Advances in stress response and crop improvement. Plant, Cell & Environment, 2025;48(7): 4823-4837.

39.             Ansabayeva A, Makhambetov M, Rebouh NY, et al. Plant growth-promoting microbes for resilient farming systems: mitigating environmental stressors and boosting crops productivity-A review. Horticulturae, 2025;11(3): 260.

40.             Nyamboga TO, Ugwu OP-C, Ugwu JN, et al. Biotechnological innovations in soil health management: a systematic review of integrating microbiome engineering, bioinformatics and sustainable practices. Cogent Food & Agriculture, 2025;11(1): 2519811.

41.             Malik MY, Naveed S, Rehman MU, et al. Geminiviruses Threats to Tropical and Subtropical Agriculture in a Warming World. Biomedical Journal of Scientific & Technical Research, 2026;65(1): 57239-57252.

42.             Dong H, Cui Y, Zhang D. CRISPR/Cas technologies and their applications in Escherichia coli. Frontiers in bioengineering and biotechnology, 2021;9: 762676.

43.             Song Z, Tao Y, Liu Y, et al. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Frontiers in Immunology, 2024;15: 1444437.

44.             Wu X, Matosevic S. Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. Molecular Therapy-Oncolytics, 2022;27: 224-238.

45.             Maqbool M, Haque E, Thacharodi A, et al. Unravelling Microbial Mysteries: The Convergence of Synthetic Biology and Metagenomics, 2024.

46.             Che S, Men Y. Synthetic microbial consortia for biosynthesis and biodegradation: promises and challenges. Journal of Industrial Microbiology and Biotechnology, 2019;46(9-10): 1343-1358.

47.             Asghar A, Sairash S, Hussain N, et al. Current challenges of biomass refinery and prospects of emerging technologies for sustainable bioproducts and bioeconomy. Biofuels, Bioproducts and Biorefining, 2022;16(6): 1478-1494.

48.             Zhang H, Li Y, Zhu J-K. Developing naturally stress-resistant crops for a sustainable agriculture. Nature Plants, 2018;4(12): 989-996.

49.             Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer drug resistance, 2019;2(2): 141.

50.             Babaniyi BR, Ogundele OD, Bisi-Omotosho A, et al. Remediation approaches in environmental sustainability. In Microbiology for cleaner production and environmental sustainability. CRC Press, 2023: 321-346.

51.             Beech CJ, Vasan S, Quinlan MM, et al. Deployment of innovative genetic vector control strategies: progress on regulatory and biosafety aspects, capacity building and development of best-practice guidance. Asia-Pacific Journal of Molecular Biology and Biotechnology, 2009;17(3): 75-85.

52.             Rozas P, Kessi-Pérez EI, Martínez C. Genetically modified organisms: adapting regulatory frameworks for evolving genome editing technologies. Biological Research, 2022;55.

53.             Søborg DA, Hendriksen NB, Kilian M, et al. Bacterial human virulence genes across diverse habitats as assessed by in silico analysis of environmental metagenomes. Frontiers in Microbiology, 2016;7: 1712.